Literature DB >> 3909566

Basement membranes in cancer.

F T Bosman, M Havenith, J P Cleutjens.   

Abstract

Basement membranes are ubiquitous tissue constituents which occur as supportive structure adjacent to epithelium, endothelium, mesothelium and also around smooth as well as striated muscle cells, Schwann cells and fat cells. In various types of cancer, basement membranes have been extensively studied by electron microscopy. Often basement membrane interruptions were seen in invasive neoplasms but in some tumors the neoplastic cells were surrounded by a continuous basal lamina. Recent immunocytochemical studies have shown that in invasive carcinomas the neoplastic cells often lack a continuous basement membrane. This may be caused by catabolic activity of invasive tumor cells, which have been shown to produce specific collagenases, or by insufficient production and/or extracellular assembly of basement membrane components by the neoplastic epithelial cells. In diagnostic histopathology, immunocytochemical staining of basement membrane components such as type IV collagen and laminin may help to distinguish between noninvasive (benign or in situ) and invasive lesions. Furthermore, in carcinomas the extent of the expression of basement membrane components may be correlated with the degree of differentiation of the neoplastic cells. Finally, in soft tissue tumors, basement membrane staining may be helpful for the differentiation of basement membrane producing neoplasms (e.g. of vascular, neural, smooth muscle or striated muscle origin) from non-basement membrane producing neoplasms (e.g. of fibroblastic origin).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3909566     DOI: 10.3109/01913128509141519

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  26 in total

Review 1.  Permeable endothelium and the interstitial space of brain.

Authors:  M W Brightman; M Kaya
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Absence of type IV collagen in the centre of the corneal epithelial basement membrane.

Authors:  J P Cleutjens; M G Havenith; M Kasper; M Vallinga; F T Bosman
Journal:  Histochem J       Date:  1990-12

3.  Heterogeneity of basement membranes in normal and pathologically altered tissues.

Authors:  I Damjanov
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 4.  Basement membrane heterogeneity.

Authors:  F T Bosman; J Cleutjens; C Beek; M Havenith
Journal:  Histochem J       Date:  1989-11

5.  Monoclonal antibodies to native basement membranes reveal heterogeneous immunoreactivity patterns.

Authors:  J P Cleutjens; M G Havenith; M Vallinga; C Beek; F T Bosman
Journal:  Histochemistry       Date:  1989

Review 6.  Use of basement membrane markers in tumour diagnosis.

Authors:  A J d'Ardenne
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

7.  Basement membrane and tumor invasion: ultrastructural observations in the basement membrane of rat bladder with invasive transitional cell carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  X H Zhang; I Takenaka
Journal:  Urol Res       Date:  1994

8.  Alteration of the basement membrane in human thyroid diseases: an immunohistochemical study of type IV collagen, laminin and heparan sulphate proteoglycan.

Authors:  R Katoh; A Muramatsu; A Kawaoi; A Komiyama; K Suzuki; A Hemmi; S Katayama
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Genes of laminin B1 chain, alpha 1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas.

Authors:  Y Soini; P Pääkkö; H Autio-Harmainen
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Gene expression profiling identifies genes predictive of oral squamous cell carcinoma.

Authors:  Chu Chen; Eduardo Méndez; John Houck; Wenhong Fan; Pawadee Lohavanichbutr; Dave Doody; Bevan Yueh; Neal D Futran; Melissa Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.